Tag - hepatocellular carcinoma (HCC)

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

September 19, 2018

👁 252 views

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation...

BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions

October 12, 2015

👁 262 views

BTG plc (LSE: BTG), a global specialist healthcare company and Mirada Medical Ltd, a medical imaging software company, today announced an important...

Tag - hepatocellular carcinoma (HCC)

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions

Press Releases

DSS Wins CTM Plus Contract from U.S. Department of Veterans Affairs

VSee Health secures FedRAMP approval, expands telehealth with ICU robot integration

Precise Launches First Unified Behavioral Health Operating System (BOS) for End-to-End Care

First Insight and Mango Voice Partner to Automate Eye Care Front Offices

Research Papers

Mount Sinai Health System to Deploy Microsoft Dragon Copilot

Ambient AI saves time, eases burnout, and strengthens patient connections

Reactions to EHR-Based Clinical Study Invitations

IDC MarketScape evaluates U.S. EHR vendors

Events Calendar

Events